Predictors of timing of adjuvant chemotherapy in older women with hormone receptor-negative, stages II-III breast cancer

Breast Cancer Research and Treatment

Volumn 131, Issue 1, 2012, Pages 207-216

  Wheeler, Stephanie B ^a   Carpenter, William R ^a   Peppercorn, Jeffrey ^b   Schenck, Anna P ^c   Weinberger, Morris ^a,d   Biddle, Andrea K ^a  

^a IL   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

Adjuvant chemotherapy; Breast cancer; Hormone receptor negative; Quality; SEER Medicare; Timing

Indexed keywords

ESTROGEN RECEPTOR; HORMONE RECEPTOR; PROGESTERONE RECEPTOR;

ADVANCED CANCER; AGE; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER STAGING; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG USE; ETHNICITY; FEMALE; HEALTH CARE QUALITY; HEALTH SERVICE; HUMAN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; PRACTICE GUIDELINE; PRIORITY JOURNAL; THERAPY DELAY; TREATMENT PLANNING; WOMEN'S HEALTH;

AGE FACTORS; AGED; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEALTHCARE DISPARITIES; HUMANS; MIDDLE AGED; NEOPLASM STAGING; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SOCIOECONOMIC FACTORS;

EID: 84856228297     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1717-6     Document Type: Article

References (52)

1. BK Edwards ML Brown PA Wingo HL Howe E Ward LAG Ries D Schrag PM Jamison A Jemal XC Wu, et al. 2005 Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer Treatment J Natl Cancer Inst 97 19 1407 1427 16204691 10.1093/jnci/dji289 (Pubitemid 41520077)
2. MJ Lund OP Brawley KC Ward JL Young SS Gabram JW Eley 2008 Parity and disparity in first course treatment of invasive breast cancer Breast Cancer Res Treat 109 3 545 557 17659438 10.1007/s10549-007-9675-8 (Pubitemid 351692062)
3. JG Zapka SH Taplin LI Solberg MM Manos 2003 A framework for improving the quality of cancer care: the case of breast and cervical cancer screening Cancer Epidemiol Biomarkers Prev 12 1 4 13 12540497 (Pubitemid 36110151)
4. D Davis M Evans A Jadad L Perrier D Rath D Ryan G Sibbald S Straus S Rappolt M Wowk, et al. 2003 The case for knowledge translation: shortening the journey from evidence to effect BMJ 327 7405 33 35 12842955 10.1136/bmj.327. 7405.33 (Pubitemid 36801894)
5. LA Carey CM Perou CA Livasy LG Dressler D Cowan K Conway G Karaca MA Troester CK Tse S Edmiston, et al. 2006 Race, breast cancer subtypes, and survival in the Carolina breast cancer study JAMA 295 21 2492 2502 16757721 1:CAS:528:DC%2BD28XlsV2rtLw%3D 10.1001/jama.295.21.2492 (Pubitemid 43854964)
6. C Anders LA Carey 2008 Understanding and treating triple-negative breast cancer Oncology (Williston Park) 22 11 1233 1239 discussion 1239-1240, 1243
7. J Peppercorn CM Perou LA Carey 2008 Molecular subtypes in breast cancer evaluation and management: divide and conquer Cancer Invest 26 1 1 10 18181038 1:CAS:528:DC%2BD1cXisFOluw%3D%3D 10.1080/07357900701784238
8. RC Millikan B Newman CK Tse PG Moorman K Conway LG Dressler LV Smith MH Labbok J Geradts JT Bensen, et al. 2008 Epidemiology of basal-like breast cancer Breast Cancer Res Treat 109 1 123 139 17578664 10.1007/s10549-007-9632-6 (Pubitemid 351538762)
9. NIH consensus conference (1991) Treatment of early-stage breast cancer. JAMA 265(3):391-395
10. CE Desch KK McNiff EC Schneider D Schrag J McClure E Lepisto MS Donaldson KL Kahn JC Weeks CY Ko 2008 American society of clinical oncology/national comprehensive cancer network quality measures J Clin Oncol 26 21 3631 3637 18640941 10.1200/JCO.2008.16.5068
11. HB Muss DA Berry CT Cirrincione M Theodoulou AM Mauer AB Kornblith AH Partridge LG Dressler HJ Cohen HP Becker, et al. 2009 Adjuvant chemotherapy in older women with early-stage breast cancer N Engl J Med 360 20 2055 2065 19439741 1:CAS:528:DC%2BD1MXmtVagsbw%3D 10.1056/NEJMoa0810266
12. T Greenhalgh G Robert F Macfarlane P Bate O Kyriakidou 2004 Diffusion of innovations in service organizations: systematic review and recommendations Milbank Q 82 4 581 629 15595944 10.1111/j.0887-378X.2004.00325.x (Pubitemid 40143100)
13. S Bowen AB Zwi 2005 Pathways to "evidence-informed" policy and practice: a framework for action PLoS Med 2 7 e166 15913387 10.1371/journal. pmed.0020166 (Pubitemid 46179269)
14. NJ Birkmeyer PP Goodney TA Stukel BE Hillner JD Birkmeyer 2005 Do cancer centers designated by the National Cancer Institute have better surgical outcomes? Cancer 103 3 435 441 15622523 10.1002/cncr.20785
15. KM Gooden DL Howard WR Carpenter AP Carson YJ Taylor S Peacock PA Godley 2008 The effect of hospital and surgeon volume on racial differences in recurrence-free survival after radical prostatectomy Med Care 46 11 1170 1176 18953228 10.1097/MLR.0b013e31817d696d
16. AM Morris KG Billingsley AJ Hayanga B Matthews LM Baldwin JD Birkmeyer 2008 Residual treatment disparities after oncology referral for rectal cancer J Natl Cancer Inst 100 10 738 744 18477800 10.1093/jnci/djn145
17. JA Talcott P Spain JA Clark WR Carpenter YK Do RJ Hamilton JA Galanko A Jackman PA Godley 2007 Hidden barriers between knowledge and behavior: the North Carolina prostate cancer screening and treatment experience Cancer 109 8 1599 1606 17354220 10.1002/cncr.22583 (Pubitemid 46595696)
18. T Onega EJ Duell X Shi E Demidenko D Gottlieb DC Goodman 2009 Influence of NCI-cancer center attendance on mortality in lung, breast, colorectal, and prostate cancer patients Med Care Res Rev 66 5 542 560 19454624 10.1177/1077558709335536
19. RT Anderson GG Kimmick F Camacho JT Whitmire C Dickinson EA Levine FM Torti R Balkrishnan 2008 Health system correlates of receipt of radiation therapy after breast-conserving surgery: a study of low-income medicaid-enrolled women Am J Manag Care 14 10 644 652 18837642
20. JL Warren CN Klabunde D Schrag PB Bach GF Riley 2002 Overview of the SEER-Medicare data: content, research applications and generalizability to the United States elderly population Med Care 40 8 Suppl IV-3-18 12187163
21. EB Elkin A Hurria N Mitra D Schrag KS Panageas 2006 Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: assessing outcome in a population-based, observational cohort J Clin Oncol 24 18 2757 2764 16782916 10.1200/JCO.2005.03.6053 (Pubitemid 46630573)
22. JL Warren LC Harlan A Fahey BA Virnig JL Freeman CN Klabunde GS Cooper KB Knopf 2002 Utility of the SEER-Medicare data to identify chemotherapy use Med Care 40 8 Suppl 1 IV-55-61
23. AT Schroen ME Lohr 2009 Travel distance to mammography and the early detection of breast cancer Breast J 15 2 216 217 19292817 10.1111/j.1524-4741. 2009.00706.x
24. AB Nattinger RT Kneusel RG Hoffmann MA Gilligan 2001 Relationship of distance from a radiotherapy facility and initial breast cancer treatment J Natl Cancer Inst 93 17 1344 1346 11535710 1:STN:280:DC%2BD3Mvptlartg%3D%3D 10.1093/jnci/93.17.1344 (Pubitemid 32910576)
25. AM Shea LH Curtis BG Hammill LD DiMartino AP Abernethy KA Schulman 2008 Association between the medicare modernization act of 2003 and patient wait times and travel distance for chemotherapy JAMA 300 2 189 196 18612116 1:CAS:528:DC%2BD1cXosVeit74%3D 10.1001/jama.300.2.189 (Pubitemid 351969303)
26. T Meden C St John-Larkin D Hermes S Sommerschield 2002 MSJAMA. Relationship between travel distance and utilization of breast cancer treatment in rural northern Michigan JAMA 287 1 111 11754721 10.1001/jama.287.1.111 (Pubitemid 34251687)
27. AT Schroen DR Brenin MD Kelly WA Knaus CL Slingluff Jr. 2005 Impact of patient distance to radiation therapy on mastectomy use in early-stage breast cancer patients J Clin Oncol 23 28 7074 7080 16192590 10.1200/JCO.2005.06.032
28. PB Bach E Guadagnoli D Schrag N Schussler JL Warren 2002 Patient demographic and socioeconomic characteristics in the SEER-Medicare database applications and limitations Med Care 40 8 IV-19-25 12187164
29. CN Klabunde JM Legler JL Warren LM Baldwin D Schrag 2007 A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients Ann Epidemiol 17 8 584 590 17531502 10.1016/j.annepidem.2007.03.011 (Pubitemid 47096709)
30. F Andre L Pusztai 2006 Molecular classification of breast cancer: implications for selection of adjuvant chemotherapy Nat Clin Pract Oncol 3 11 621 632 17080180 10.1038/ncponc0636 (Pubitemid 44669717)
31. SE Singletary JL Connolly 2006 Breast cancer staging: working with the sixth edition of the AJCC Cancer Staging Manual CA Cancer J Clin 56 1 37 47 16449185 10.3322/canjclin.56.1.37 quiz 50-31 (Pubitemid 43228386)
32. M Banerjee J George C Yee W Hryniuk K Schwartz 2007 Disentangling the effects of race on breast cancer treatment Cancer 110 10 2169 2177 17924374 10.1002/cncr.23026 (Pubitemid 350100737)
33. JS Haas CC Earle JE Orav P Brawarsky M Keohane BA Neville DR Williams 2008 Racial segregation and disparities in breast cancer care and mortality Cancer 113 8 2166 2172 18798230 10.1002/cncr.23828
34. M Schootman DB Jeffe M Lian WE Gillanders R Aft 2009 The role of poverty rate and racial distribution in the geographic clustering of breast cancer survival among older women: a geographic and multilevel analysis Am J Epidemiol 169 5 554 561 19103608 10.1093/aje/kwn369
35. Y Bao SA Fox JJ Escarce 2007 Socioeconomic and racial/ethnic differences in the discussion of cancer screening: "between-" versus "within-" physician differences Health Serv Res 42 3 Pt 1 950 970 17489898 10.1111/j.1475-6773.2006.00638.x (Pubitemid 46699468)
36. A Bhargava XL Du 2009 Racial and socioeconomic disparities in adjuvant chemotherapy for older women with lymph node-positive, operable breast cancer Cancer 115 13 2999 3008 19452539 10.1002/cncr.24363
37. Pagano M, Gauvreau K (2000) Principles of biostatistics, 2nd edn. Duxbury Press, Pacific Grove
38. Rothman KJ, Greenland S, Lash TL (2008) Modern epidemiology, 3rd edn. Lippincott Williams & Wilkins, Philadelphia
39. Wooldridge JM (2006) Introductory econometrics-a modern approach. Thomson-Southwestern, Mason
40. XL Du CR Key C Osborne JD Mahnken JS Goodwin 2003 Discrepancy between consensus recommendations and actual community use of adjuvant chemotherapy in women with breast cancer Ann Intern Med 138 2 90 97 12529090 (Pubitemid 36222495)
41. X Du JS Goodwin 2001 Patterns of use of chemotherapy for breast cancer in older women: findings from Medicare claims data J Clin Oncol 19 5 1455 1461 11230491 1:STN:280:DC%2BD3M7osVGrug%3D%3D (Pubitemid 32202553)
42. SH Giordano Z Duan YF Kuo GN Hortobagyi JS Goodwin 2006 Use and outcomes of adjuvant chemotherapy in older women with breast cancer J Clin Oncol 24 18 2750 2756 16782915 10.1200/JCO.2005.02.3028 (Pubitemid 46630572)
43. KJ Passage NJ McCarthy 2007 Critical review of the management of early-stage breast cancer in elderly women Intern Med J 37 3 181 189 17316337 1:STN:280:DC%2BD2s7hvF2lsA%3D%3D 10.1111/j.1445-5994.2007.01269.x
44. H Wildiers EG Brain 2005 Adjuvant chemotherapy in elderly patients with breast cancer: where are we? Curr Opin Oncol 17 6 566 572 16224234 1:CAS:528:DC%2BD2MXhtFSis7%2FI 10.1097/01.cco.0000180433.93872.d3 (Pubitemid 41566409)
45. SH Giordano S Fang Z Duan YF Kuo GN Hortobagyi JS Goodwin 2008 Use of intravenous bisphosphonates in older women with breast cancer Oncologist 13 5 494 502 18515734 10.1634/theoncologist.2007-0200 (Pubitemid 351872867)
46. C Owusu TL Lash RA Silliman 2007 Effect of undertreatment on the disparity in age-related breast cancer-specific survival among older women Breast Cancer Res Treat 102 2 227 236 17004115 10.1007/s10549-006-9321-x (Pubitemid 46452169)
47. NA Bickell JJ Wang S Oluwole D Schrag H Godfrey K Hiotis J Mendez AA Guth 2006 Missed opportunities: racial disparities in adjuvant breast cancer treatment J Clin Oncol 24 9 1357 1362 16549830 10.1200/JCO.2005.04.5799 (Pubitemid 46621998)
48. Enewold L, Zhou J, McGlynn KA, Anderson WF, Shriver CD, Potter JF, Zahm SH, Zhu K (2011) Racial variation in breast cancer treatment among department of defense beneficiaries. Cancer doi: 10.1002/cncr.26346
49. R Chaudhry V Goel C Sawka 2001 Breast cancer survival by teaching status of the initial treating hospital CMAJ 164 2 183 188 11332310 1:STN:280:DC%2BD3M3mt1ClsA%3D%3D (Pubitemid 32157740)
50. N Hebert-Croteau J Brisson J Lemaire J Latreille R Pineault 2005 Investigating the correlation between hospital of primary treatment and the survival of women with breast cancer Cancer 104 7 1343 1348 16080144 10.1002/cncr.21336 (Pubitemid 41356148)
51. L Laliberte ML Fennell G Papandonatos 2005 The relationship of membership in research networks to compliance with treatment guidelines for early-stage breast cancer Med Care 43 5 471 479 15838412 10.1097/01.mlr.0000160416.66188.f5 (Pubitemid 40694608)
52. DL Hershman X Wang R McBride JS Jacobson VR Grann AI Neugut 2006 Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women Breast Cancer Res Treat 99 3 313 321 16583264 1:CAS:528: DC%2BD28XptVWqs7Y%3D 10.1007/s10549-006-9206-z (Pubitemid 44337924)